Title : Emerging strategies for the treatment of mutant Bcr-Abl T315I myeloid leukemia.

Pub. Date : 2007 Mar

PMID : 17382017






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 One of the more common mutations results from the substitution of isoleucine for threonine at Abl amino acid position 351, known as the T315I mutation. Threonine ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens